Navigation Links
Medicare HMO costs may prevent cancer patient clinical trial participation
Date:9/23/2008

PITTSBURGH, Sept. 23 Newly diagnosed cancer patients who are enrolled in Medicare's Health Maintenance Organization (HMO) plans may be unlikely to participate in clinical trials because of prohibitive costs, according to a study by the University of Pittsburgh Cancer Institute (UPCI). Under these HMO plans, covering people age 65 and older, patients are required to pay both a deductible and 20 percent of the treatment cost. As a result, access to state-of-the-art care is limited for some of society's most vulnerable members. This research will be announced during the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.

According to Chyongchiou Lin, Ph.D., lead author of the study and associate professor of health economics in UPCI's Department of Radiation Oncology, two-thirds of cancer patients are age 65 or older, with 60 percent of new cancersand 70 percent of cancer-related deathsoccurring in this age group. At the same time, less than one-third of clinical trial enrollees fall into this age group, and patients often cite cost and insurance coverage as barriers to their participation. Because the Medicare HMO payment policy requires significant personal expense, Dr. Lin and her team believe the disparity in clinical trials representation and the payment policy are likely to be related.

"Clinical trials are the cornerstone in finding better, more effective cancer treatments," said Dr. Lin. "The National Cancer Institute (NCI) has made clinical trial participation a national priority, yet current Medicare reimbursement policies present a participation barrier for a large number of patients, cutting them off from cutting-edge treatments. The current policy should be re-examined to be consistent with NCI initiatives."

The study shows the overall proportion of newly diagnosed cancer patients who had consultations and were insured by Medicare HMOs increased from 21 percent in 2003 to 27 percent in
'/>"/>

Contact: Courtney McCrimmon
McCrimmonCP@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Los Angeles Jury Convicts Defendant of Fraud Involving More Than $1.1 Million in False Billing to Medicare
2. Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions
3. Miami HIV Clinic Administrator Pleads Guilty for Role in a $14 Million Medicare Fraud Scheme
4. Extra payments to Medicare Advantage plans to total $8.5 billion in 2008
5. Demystifying Medicare and Long Term Care Insurance - Healthcare Liaison Workshop 9/20 Shows Consumers How to Make Choices
6. Power Mobility Coalition Voices Concern Over Government Reports Outlining Lack of Oversight in the Medicare Durable Medical Equipment Benefit
7. Medicare Advantage Plans Struggle to Comply With New Federal Law
8. Medicare Web Site Confounds Many Seniors
9. Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds
10. Senator Pat Roberts Praised for Leading Successful Effort to Derail $6.2 Million Kansas Medicare Cuts
11. Senator Susan Collins Praised for Leading Successful Effort to Derail $4.3 Million Maine Medicare Cuts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The market for botulinum neurotoxin (BoNT) products ... to novel medical indications created and due to more ... where physical appearance is extremely valued. Although the BoNT ... new companies and technologies are setting ground for biosuperiors ... the price of 1st-gen products under pressure, only innovation ...
(Date:7/22/2014)... NJ (PRWEB) July 22, 2014 CarePoint Health ... recently elected as the President of the medical staff at ... Levine will serve as President, as voted on by the ... of the medical staff in relation to the administration at ... needs of physicians and to work to make the Medical ...
(Date:7/22/2014)... The Middle East Drilling fluid and Completion fluid Market ... market in Middle East with analysis and forecast of revenue. ... is estimated to grow from around $560 million in 2013 ... for the given period. , Browse through the TOC of ... to get an idea of the in-depth analysis provided. This ...
(Date:7/22/2014)... Over the years, medical science ... of human anatomy. In the pursuit, pathological sciences, ... the possibility of deploying certain tests that are ... in order to detect the presence of concerning ... Diagnostics (IVD) have earned the title of ‘silent ...
(Date:7/22/2014)... How can women meet the demands of a professorship ... a mother has a profound effect on the career ... physical sciences. Yet many women successfully manage to do ... fifteen inspirational personal accounts describe the challenges and rewards ... , The authors of the contributions are all women ...
Breaking Medicine News(10 mins):Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4
... Calif., June 23 Consumer,Watchdog warned today that a ... it,more difficult for patients to recover unpaid medical bills ... illegal and,unwarranted. The legislation and recent settlements with regulators ... from legal,liability under the guise of reform., AB ...
... patients who need little, if any, immune suppression , , ... called HLA-G dimer plays a powerful role in preventing ... Medical College of Georgia researchers say. , They ... mice and are currently studying whether this molecule is ...
... than 15 years ago scientists discovered a way to ... Prize-winning finding holds tantalizing promise for medical science, but ... technique, known as RNA interference, in living cells., Now ... Emory University in Atlanta have succeeded in using nanotechnology ...
... 23 Quest Diagnostics,Incorporated (NYSE: DGX ), ... services, announced that it is scheduled to speak,at ... 2008. The Quest,Diagnostics presentation is scheduled to begin ... be webcast live during the conference and will ...
... Ky., June 23 The following open,letter to Senator ... "Quitting isn,t that easy, ChicagoTribune.com, June 22, ... great interest your recent comments about your struggle,to quit ... research,program focused on tobacco use and its consequences, I ...
... Crash Diets Often Crash-and-Burn, WASHINGTON, June 23 ... weighed in today on a,weight-loss story in the headlines, ... little more than a crash diet, not the kind ... Chris Coleson, a 42-year old Quinton, Virginia man ...
Cached Medicine News:Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 2Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 3Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 4Health News:CA Legislature's 'Reform' of Health Insurance Cancellations Resembles Insurance Industry's Own Plan; Insurers, Satisfied With Getting a Legal Edge Against Patients, Drop Opposition to the Bill 5Health News:Immune Molecule Key to Preventing Organ Rejection 2Health News:Gene silencer and quantum dots reduce protein production to a whisper 2Health News:Gene silencer and quantum dots reduce protein production to a whisper 3Health News:'Quitting Isn't That Easy' 2Health News:'Quitting Isn't That Easy' 3Health News:Experts Fact-Check 'McDonald's Diet' Story 2
(Date:7/22/2014)... England , July 22, 2014 ... development and device company focused on solid dose ... its novel solid formulation of octreotide acetate achieved ... it with the currently marketed liquid product (Sandostatin®). ... transfer the formulation production process to a contract ...
(Date:7/21/2014)... /PRNewswire-iReach/ -- Nitrosolution.com, a website that features safe and ... first anniversary in August. The online retailer specializes in ... body,s ability to produce nitric oxide. Called Nitroxyl, it ... a variety of phytonutrients and other natural ingredients that ... nitric oxide production in the arteries and ...
(Date:7/21/2014)... , July 21, 2014 Thoratec Corporation (NASDAQ: ... mechanical circulatory support therapies to save, support and restore ... operating results for the second quarter of fiscal year ... will hold a conference call to discuss its financial ... at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern ...
Breaking Medicine Technology:Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2Thoratec Schedules Second Quarter Conference Call, Webcast 2
... 12 Lexicon,Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... drug (IND) application to the U.S. Food and ... for rheumatoid,arthritis and other autoimmune conditions. The initial ... a double-blind, randomized,placebo-controlled, ascending single-dose study in healthy ...
... Medical Lasers Limited,(ASX: ELX), a global leader in ... systems, announced today initial clinical results of,an ongoing ... demonstrate the therapy,s potential to improve and,stabilize visual ... with,diabetic maculopathy and macular edema without causing any ...
Cached Medicine Technology:Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 2Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 4
... To aid clinicians in performing Ankle/Brachial ... a new, complete packet of information. It ... presentation that can be viewed on any ... the step-by-step procedure of performing an ABI ...
... Auto Refractor/Keratometer. Advanced engineering, ... retro illumination mode make it the ... use. 5.5 inch High Quality ... focusing. Rapid, instantaneous readings are taken ...
... for Urinary Tract Infection (UTI) ... A multi-center study was conducted ... UTIs. There were 1,887 urine ... and nitrite results of Multistix ...
... PocketChem UA is the first ... take up valuable lab bench space. ... the variability in results between operators ... on every run, corrects for ambient ...
Medicine Products: